Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case

Pulmonary Infection Caused by Achromobacter xylosoxidans in a Patient with Carcinoma of Epiglottis: A Rare Case

Achromobacter xylosoxidans is an aerobic, motile, oxidase and catalase positive, non-fermenting, gram negative bacillus. It is an opportunistic pathogen which is responsible for various nosocomial and community-acquired infections. However, there are only very few reports of pulmonary infections c...

Full description

Bibliographic Details
Main Author:	Priyamvada Roy
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2014-05-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	achromobacter xylosoxidans granulocyte colony stimulating factor malignancy pneumonia
Online Access:	https://jcdr.net/articles/PDF/4329/7940_CE(Ra)_E(C)_F(H)_PF1(AGH)_PFA(P)_PF2(PAG)p.pdf

Similar Items

A case of community-acquired spondylodiscitis caused by Achromobacter xylosoxidans
by: T. Brochet, et al.
Published: (2024-01-01)

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
by: M.C. Firmida, et al.
Published: (2016-01-01)

Resolution of concomitant Achromobacter xylosoxidans burn wound infection without adjustment of antimicrobial therapy
by: Zhi Yang Ng, et al.
Published: (2014-01-01)

Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome
by: Ozden Turel, et al.

Retroperitoneal abscess due to Achromobacter xylosoxidans presenting as femoral pain
by: Yoshihiro Kawaguchi, et al.
Published: (2020-07-01)

Skull Base Osteomyelitis Caused by Achromobacter xylosoxidans
by: Sunayana M. Jangla, et al.
Published: (2020-10-01)

Late aortic prosthetic valve endocarditis due to Achromobacter xylosoxidans infection: a case report and review of the literature
by: A. Mastroianni, et al.
Published: (2023-10-01)

Pneumonia due to Achromobacter xylosoxidans with a chronic course resembling non‐tuberculous mycobacterial infection
by: Tomoko Kotani, et al.
Published: (2024-02-01)

Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014
by: Skerdi Haviari, et al.
Published: (2016-08-01)

Chronic, Recurrent Bacterial Endophthalmitis Caused by Achromobacter xylosoxidans: Clinical Features and Management
by: Lazzarini TA, et al.
Published: (2020-07-01)

Chronic osteomyelitis caused by Achromobacter xylosoxidans following orthopaedic trauma: A case report and review of the literature
by: Sahand Imani, et al.
Published: (2021-01-01)

Comprehensive toxicological, metabolomic, and transcriptomic analysis of the biodegradation and adaptation mechanism by Achromobacter xylosoxidans SL-6 to diuron
by: Zhixu Hu, et al.
Published: (2024-06-01)

Uncommon pathogen: Serious manifestation: A rare case of Achromobacter xylosoxidans septic arthritis in immunocompetetant patient
by: Kalpana Tikaram Suryavanshi, et al.
Published: (2015-01-01)

Respiratory infections by Achromobacter xylosoxidans in a cohort of Cystic Fibrosis patients: identification, antimicrobial susceptibility and molecular epidemiology
by: Antonietta Lambiase, et al.
Published: (2010-03-01)

Adaptation of metal and antibiotic resistant traits in novel β-Proteobacterium Achromobacter xylosoxidans BHW-15
by: Arif Istiaq, et al.
Published: (2019-03-01)

Motility, Biofilm Formation and Antimicrobial Efflux of Sessile and Planktonic Cells of <i>Achromobacter xylosoxidans</i>
by: Signe M. Nielsen, et al.
Published: (2019-01-01)

Prevalence and variability of siderophore production in the Achromobacter genus
by: P. Sorlin, et al.
Published: (2024-03-01)

Legume Nodulating Bacterium, Achromobacter xylosoxidans Found in Tropical Shrub Agroecosystem, Sumatera, Indonesia
by: Sri Wedhastri, et al.
Published: (2013-12-01)

Immunoinformatic Approach to Contrive a Next Generation Multi-Epitope Vaccine Against Achromobacter xylosoxidans Infections
by: Kashaf Khalid, et al.
Published: (2022-07-01)

Exoproducts of the Most Common Achromobacter Species in Cystic Fibrosis Evoke Similar Inflammatory Responses In Vitro
by: Cecilia Sahl, et al.
Published: (2023-08-01)

VEB-1 in Achromobacter xylosoxidans from Cystic Fibrosis Patient, France
by: Catherine Neuwirth, et al.
Published: (2006-11-01)

Osteomyelitis caused by Achromobacter xylosoxidans
by: Takashi Shinha, et al.
Published: (2015-01-01)

Antimicrobial Susceptibility Pattern and Prevalence of the Emerging Nosocomial Pathogen Achromobacter xylosoxidans in a North Indian Tertiary Care Hospital
by: Malvika Singh, et al.
Published: (2023-12-01)

The twin-arginine translocation system is vital for cell adhesion and uptake of iron in the cystic fibrosis pathogen Achromobacter xylosoxidans
by: S. M. Hossein Khademi, et al.
Published: (2024-12-01)

Community-acquired infection presenting as a cavitary lung disease in an immunocompetent patient
by: Chan Hee Hwang, et al.
Published: (2020-01-01)

Evaluation of the Whole Proteome of Achromobacter xylosoxidans to Identify Vaccine Targets for mRNA and Peptides-Based Vaccine Designing Against the Emerging Respiratory and Lung Cancer-Causing Bacteria
by: Taimoor Khan, et al.
Published: (2022-02-01)

A Case of Phage Therapy against Pandrug-Resistant <i>Achromobacter xylosoxidans</i> in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient
by: David Lebeaux, et al.
Published: (2021-01-01)

Identification of Non-fermenters by Matrix Assisted Laser Desorption/Ionisation- Time of Flight Mass Spectrometry: Case Series of Achromobacter Infections
by: Pratik Thosani, et al.
Published: (2020-10-01)

Chronic otomastoiditis and otitis externa caused by Achromobacter xylosoxidans
by: Steven Curry, et al.
Published: (2020-11-01)

The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on <i>Achromobacter xylosoxidans</i> in a Cystic Fibrosis Sputum/Lung Cell Model
by: Aditi Aiyer, et al.
Published: (2022-11-01)

An 18-Year Dataset on the Clinical Incidence and MICs to Antibiotics of <i>Achromobacter</i> spp. (Labeled Biochemically or by MAL-DI-TOF MS as <i>A. xylosoxidans</i>), Largely in Patient Groups Other than Those with CF
by: Claudio Neidhöfer, et al.
Published: (2022-02-01)

Native-valve endocarditis caused by Achromobacter xylosoxidans: a case report and review of literature
by: Caio Godoy Rodrigues, et al.
Published: (2017-09-01)

Postoperative meningitis due to a rare pathogen; Alcaligenes xylosoxidans
by: Ozer Burcin, et al.
Published: (2009-12-01)

Role of Efflux in Antibiotic Resistance of Achromobacter xylosoxidans and Achromobacter insuavis Isolates From Patients With Cystic Fibrosis
by: Hussein Chalhoub, et al.
Published: (2022-03-01)

Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014
by: Lucie Amoureux, et al.
Published: (2019-11-01)

The In Vitro Replication Cycle of Achromobacter xylosoxidans and Identification of Virulence Genes Associated with Cytotoxicity in Macrophages
by: Adam M. Pickrum, et al.
Published: (2022-08-01)

A Rarely Cause Of Urinary And Bloodstream Infections: Achromobacter Spp
by: Elif DEDE, et al.
Published: (2024-12-01)

Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports
by: Terenzio Cosio, et al.
Published: (2023-11-01)

Bioaugmentation of PAH-Contaminated Soils With Novel Specific Degrader Strains Isolated From a Contaminated Industrial Site. Effect of Hydroxypropyl-β-Cyclodextrin as PAH Bioavailability Enhancer
by: Jaime Villaverde, et al.
Published: (2019-11-01)

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis
by: Quentin Menetrey, et al.
Published: (2020-09-01)